Analysts downgrade Kraft Heinz and Biogen as market outlook shifts

benzinga.com

Analysts have downgraded several major companies. Deutsche Bank lowered Kraft Heinz's rating from Buy to Hold, reducing the price target from $39 to $35. Kraft Heinz shares closed at $33.73. Morgan Stanley downgraded Biogen from Overweight to Equal-Weight, cutting the price target from $285 to $204. Biogen shares ended at $181.18. JP Morgan downgraded Brinker International from Overweight to Neutral but raised the price target from $67 to $100. Bernstein downgraded Arm Holdings from Market Perform to Underperform, maintaining a $100 price target.


With a significance score of 3.1, this news ranks in the top 11% of today's 29067 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Analysts downgrade Kraft Heinz and Biogen as market outlook shifts | News Minimalist